Does Epclusa Interact with Acid Reflux Medications?
Epclusa (sofosbuvir/velpatasvir), a hepatitis C treatment, has a moderate interaction with proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and pantoprazole—the most common acid reflux drugs. Velpatasvir's absorption decreases in higher stomach pH from PPIs, potentially reducing Epclusa effectiveness. H2 blockers like famotidine and antacids like calcium carbonate also interact but to a lesser degree.[1][2]
How Should You Take Epclusa with PPIs?
Take Epclusa with food 4 hours before or 12 hours after a PPI dose (e.g., omeprazole 20 mg). Limit PPI to the lowest effective dose for the shortest time. Higher PPI doses or twice-daily use increase interaction risk.[1][3]
What About H2 Blockers or Antacids?
H2 blockers (e.g., ranitidine, famotidine) can be taken simultaneously with Epclusa. Separate antacids containing magnesium, aluminum, or calcium by at least 4 hours. No major issues with these if timed properly.[1][2]
Why Does This Interaction Happen?
Velpatasvir solubility drops at pH above 5, common with acid reducers. Sofosbuvir is unaffected. Clinical studies showed 30-40% velpatasvir exposure drop with high-dose omeprazole, prompting FDA labeling warnings.[3][4]
Are There Safer Acid Reflux Alternatives?
Switch to on-demand antacids or H2 blockers if possible. Sucralfate lacks interaction but coats the stomach. Consult a doctor before changes—untreated reflux risks outweigh adjusted Epclusa dosing.[2][5]
What Do Real-World Studies and Labels Say?
Phase 3 trials confirmed reduced cure rates (below 90%) with unadjusted PPI use. Epclusa prescribing info mandates timing; no full contraindication. Monitor HCV RNA if interaction suspected.[3][4]
[1]: Epclusa Prescribing Information (Gilead)
[2]: Drugs.com - Epclusa Interactions
[3]: FDA Label for Epclusa
[4]: Hepatology Journal - Velpatasvir PK Study (2017)
[5]: American College of Gastroenterology - GERD Guidelines